SitaXA 50mg Tablet contains Sitagliptin, a DPP-4 inhibitor used to improve blood sugar control in adults with Type 2 Diabetes Mellitus. It works by increasing incretin hormone levels in the body, which help stimulate insulin release after meals and reduce excess glucose production by the liver.
This helps maintain stable blood sugar throughout the day and reduces post-meal spikes. Sitagliptin is commonly used alone or in combination with other diabetes medicines like metformin, sulfonylureas, or insulin.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Increases insulin secretion
-
Reduces glucose production
-
Helps prevent diabetes-related complications
Dosage:
How to Use:
-
Swallow the tablet whole with water
-
Take it at the same time every day
-
Continue prescribed diet and exercise for best results
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Dose adjustment may be needed in patients with kidney disease
-
Use caution if you have a history of pancreatitis
-
Pregnant or breastfeeding women should consult a doctor
Side Effects:
SitaXA D 10mg/100mg Tablet is a combination anti-diabetic medication containing Dapagliflozin and Sitagliptin. Dapagliflozin, an SGLT2 inhibitor, lowers blood sugar by increasing glucose excretion through urine. Sitagliptin, a DPP-4 inhibitor, enhances incretin hormone activity, stimulating insulin release and reducing post-meal glucose production.
This combination is prescribed for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy does not provide adequate blood sugar control.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Improves insulin secretion
-
Helps with weight management via glucose excretion
-
Supports prevention of diabetes-related complications
Dosage:
How to Use:
-
Swallow the tablet whole with water
-
Take at the same time each day
-
Maintain diet and exercise as prescribed
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney disease or urinary tract infections
-
Monitor for dehydration or low blood pressure
-
Consult doctor if pregnant or breastfeeding
Side Effects:
SitaXA D 10mg/50mg Tablet is a combination anti-diabetic medicine containing Dapagliflozin and Sitagliptin. Dapagliflozin is an SGLT2 inhibitor that reduces blood glucose by promoting glucose excretion through urine. Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity, stimulating insulin release and reducing post-meal glucose production.
This combination is used for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy alone does not achieve adequate glycemic control.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Enhances insulin secretion
-
Supports weight management through glucose excretion
-
Helps prevent diabetes-related complications
Dosage:
How to Use:
-
Swallow the tablet whole with water
-
Take at the same time each day
-
Continue prescribed diet and exercise routine
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney disease or urinary tract infections
-
Monitor for dehydration or low blood pressure
-
Consult doctor if pregnant or breastfeeding
Side Effects:
SitaXA D 50+5 Tablet is a combination anti-diabetic medication containing Dapagliflozin and Sitagliptin. Dapagliflozin is an SGLT2 inhibitor that helps lower blood sugar by increasing glucose excretion through urine. Sitagliptin is a DPP-4 inhibitor that enhances incretin hormone activity, increasing insulin secretion and reducing glucose production after meals.
This combination is used in adults with Type 2 Diabetes Mellitus to achieve better glycemic control when diet, exercise, or monotherapy is insufficient.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Improves insulin secretion
-
Supports weight management through glucose excretion
-
Helps prevent diabetes-related complications
Dosage:
How to Use:
-
Swallow the tablet whole with water
-
Take at the same time each day
-
Maintain proper diet and exercise as prescribed
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in kidney disease or urinary tract infections
-
Monitor for signs of dehydration or low blood pressure
-
Consult a doctor if pregnant or breastfeeding
Side Effects:
SitaXA DM 10/100/500 Tablet ER is an extended-release combination anti-diabetic medicine containing Dapagliflozin, Metformin, and Sitagliptin. Dapagliflozin (SGLT2 inhibitor) lowers blood sugar by promoting glucose excretion through urine. Metformin (biguanide) decreases liver glucose production and improves insulin sensitivity. Sitagliptin (DPP-4 inhibitor) enhances incretin hormone activity, increasing insulin secretion and reducing post-meal glucose production.
The extended-release (ER) formulation ensures gradual release of metformin, reducing gastrointestinal side effects while providing effective blood sugar control throughout the day. This combination is used for adults with Type 2 Diabetes Mellitus when diet, exercise, or dual therapy alone is insufficient.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Improves insulin secretion and sensitivity
-
Supports weight management via glucose excretion
-
Helps prevent diabetes-related complications
Dosage:
-
Usually one tablet once daily, or as directed by the doctor
-
Take with meals to minimize gastrointestinal discomfort
How to Use:
-
Swallow the tablet whole with water; do not crush or chew
-
Take at the same time each day
-
Maintain diet and exercise as prescribed
Precautions:
-
Not suitable for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney or liver disease
-
Monitor for dehydration or urinary/genital infections
-
Consult doctor if pregnant or breastfeeding
Side Effects:
-
Nausea, vomiting, diarrhea, or stomach discomfort
-
Increased urination
-
Urinary tract or genital infections
-
Low blood sugar (hypoglycemia) if combined with other anti-diabetic drugs
-
Rare: allergic reactions
Sitaxa E 25+100 Tablet is a combination anti-diabetic medication containing Empagliflozin and Sitagliptin. Empagliflozin, an SGLT2 inhibitor, lowers blood sugar by promoting glucose excretion through urine. Sitagliptin, a DPP-4 inhibitor, enhances incretin hormone activity, stimulating insulin secretion and reducing post-meal glucose production.
This combination is prescribed for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy does not achieve adequate glycemic control.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Enhances insulin secretion
-
Supports weight management via glucose excretion
-
Helps prevent diabetes-related complications
Dosage:
How to Use:
-
Swallow the tablet whole with water
-
Take at the same time each day
-
Continue prescribed diet and exercise routine
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney disease or urinary tract infections
-
Monitor for dehydration or low blood pressure
-
Consult doctor if pregnant or breastfeeding
Side Effects:
SiTaxa M 50/1000 Tablet is a combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity, stimulating insulin release and reducing glucose production after meals. Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity.
This combination is used in adults with Type 2 Diabetes Mellitus to control blood sugar levels when diet, exercise, or monotherapy is insufficient.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Improves insulin sensitivity
-
Helps prevent diabetes-related complications
Dosage:
-
Usually one tablet twice daily, or as prescribed by the doctor
-
Take with meals to reduce gastrointestinal discomfort
How to Use:
-
Swallow the tablet whole with water
-
Take at the same times every day
-
Follow a proper diet and exercise routine
Precautions:
-
Not suitable for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney or liver disease
-
Inform doctor if there is a history of pancreatitis
-
Consult doctor if pregnant or breastfeeding
Side Effects:
-
Nausea, vomiting, or diarrhea
-
Stomach upset or abdominal discomfort
-
Headache
-
Low blood sugar (hypoglycemia) when combined with other anti-diabetic drugs
-
Rare: allergic reactions
SiTaxa M 50mg/500mg Tablet is a combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that enhances incretin hormone activity, increasing insulin release and reducing glucose production after meals. Metformin, a biguanide, works by decreasing glucose production in the liver and improving insulin sensitivity.
This combination helps control blood sugar levels in adults with Type 2 Diabetes Mellitus, especially when diet and exercise alone are insufficient.
Uses:
-
Manages Type 2 diabetes
-
Reduces high blood sugar levels after meals
-
Improves insulin sensitivity
-
Helps prevent diabetes-related complications
Dosage:
-
Typically one tablet twice daily, or as prescribed by the doctor
-
Take with meals to reduce gastrointestinal side effects
How to Use:
-
Swallow the tablet whole with water
-
Take at the same times each day for consistent blood sugar control
-
Continue prescribed diet and exercise
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use with caution in patients with kidney or liver issues
-
Inform doctor if history of pancreatitis exists
-
Consult doctor if pregnant or breastfeeding
Side Effects:
-
Nausea, vomiting, or diarrhea
-
Stomach discomfort
-
Headache
-
Low blood sugar (especially if combined with other anti-diabetic drugs)
-
Rare: allergic reactions
Sitaxa M XR 100+1000 Tablet is an extended-release combination anti-diabetic medicine containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that enhances incretin hormone activity, stimulating insulin secretion after meals and reducing glucose production. Metformin, a biguanide, decreases hepatic glucose production and improves insulin sensitivity.
The extended-release (ER) formulation ensures gradual release of metformin, reducing gastrointestinal side effects and providing sustained blood sugar control throughout the day. It is indicated for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy is insufficient.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Improves insulin sensitivity
-
Helps prevent diabetes-related complications
Dosage:
-
Usually one tablet once daily, or as prescribed by the doctor
-
Take with meals to minimize gastrointestinal discomfort
How to Use:
-
Swallow the tablet whole with water; do not crush or chew
-
Take at the same time every day
-
Continue prescribed diet and exercise routine
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney or liver disease
-
Inform doctor if there is a history of pancreatitis
-
Consult a doctor if pregnant or breastfeeding
Side Effects:
-
Nausea, vomiting, diarrhea, or stomach upset
-
Headache
-
Low blood sugar (hypoglycemia) when combined with other anti-diabetic drugs
-
Rare: allergic reactions
SiTaxa M XR 100+500 Tablet is an extended-release combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin, a DPP-4 inhibitor, enhances incretin hormone activity, increasing insulin secretion after meals and reducing glucose production. Metformin decreases hepatic glucose production and improves insulin sensitivity.
The extended-release (ER) formulation allows gradual release of metformin, improving blood sugar control and minimizing gastrointestinal side effects. It is prescribed for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy alone is insufficient.
Uses:
-
Controls high blood sugar in Type 2 diabetes
-
Reduces post-meal glucose spikes
-
Improves insulin sensitivity
-
Helps prevent diabetes-related complications
Dosage:
-
Typically one tablet once daily, or as directed by the doctor
-
Take with meals to reduce gastrointestinal discomfort
How to Use:
-
Swallow the tablet whole with water; do not crush or chew
-
Take at the same time each day for consistent blood sugar control
-
Maintain prescribed diet and exercise routine
Precautions:
-
Not suitable for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in patients with kidney or liver issues
-
Inform doctor if history of pancreatitis exists
-
Consult a doctor if pregnant or breastfeeding
Side Effects:
-
Nausea, vomiting, diarrhea, or stomach discomfort
-
Headache
-
Low blood sugar (hypoglycemia) when combined with other anti-diabetic drugs
-
Rare: allergic reactions
SiTaxa M XR 50+500 Tablet ER is an extended-release combination anti-diabetic medication containing Sitagliptin and Metformin. Sitagliptin is a DPP-4 inhibitor that increases incretin hormone activity, enhancing insulin secretion and reducing post-meal glucose production. Metformin, a biguanide, decreases liver glucose production and improves insulin sensitivity.
The extended-release (ER) formulation ensures gradual release of metformin, reducing gastrointestinal side effects and providing better blood sugar control throughout the day. It is indicated for adults with Type 2 Diabetes Mellitus when diet, exercise, or monotherapy is insufficient.
Uses:
-
Manages Type 2 diabetes
-
Reduces high blood sugar levels, especially after meals
-
Improves insulin sensitivity
-
Helps prevent diabetes-related complications
Dosage:
-
Usually one tablet once daily, or as prescribed by the doctor
-
Take with meals to minimize gastrointestinal discomfort
How to Use:
-
Swallow the tablet whole with water; do not crush or chew
-
Take at the same time each day
-
Follow a proper diet and exercise regimen
Precautions:
-
Not for Type 1 diabetes or diabetic ketoacidosis
-
Use cautiously in kidney or liver disease
-
Inform doctor if history of pancreatitis
-
Consult a doctor if pregnant or breastfeeding
Side Effects:
-
Nausea, vomiting, diarrhea, or abdominal discomfort
-
Headache
-
Low blood sugar (hypoglycemia) if used with other anti-diabetic drugs
-
Rare: allergic reactions
Sitazit 100mg Tablet contains Sitagliptin 100mg, an oral antidiabetic medicine belonging to the class of DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors). It helps control blood sugar levels in type 2 diabetes mellitus by increasing the levels of incretin hormones, which stimulate insulin release and reduce glucose production in the liver. This ensures better glycemic control without causing significant hypoglycemia.
Uses of Sitazit 100mg Tablet
-
Management of type 2 diabetes mellitus
-
Helps in lowering fasting and post-meal blood glucose
-
Can be used as monotherapy or in combination with other antidiabetic drugs (e.g., metformin, sulfonylureas, SGLT2 inhibitors)
-
Reduces the risk of diabetes-related complications
How to Use
-
Take the tablet once daily or as prescribed by your doctor.
-
Can be taken with or without food.
-
Maintain a balanced diabetic diet and regular exercise routine for maximum benefit.
-
Do not stop the medication without consulting your doctor.
Side Effects
Common:
Rare but serious:
-
Pancreatitis (severe abdominal pain)
-
Allergic reactions – rash, swelling, difficulty breathing
-
Hypoglycemia (when used with other antidiabetics)
Precautions & Warnings
-
Prescription Required – take only under medical guidance.
-
Not recommended in patients with type 1 diabetes or diabetic ketoacidosis.
-
Use with caution in kidney impairment; dose adjustment may be necessary.
-
Inform your doctor if you have a history of pancreatitis or heart disease.
-
Safe use during pregnancy and breastfeeding has not been established.
Conclusion
Sitazit 100mg Tablet (Sitagliptin 100mg) is an effective DPP-4 inhibitor for type 2 diabetes management, helping improve blood sugar control with a low risk of hypoglycemia. When combined with a healthy lifestyle, diet, and exercise, it supports better glycemic control and reduces long-term diabetes-related complications under proper medical supervision.